Trending Now
Oncolytics Biotech, Inc. (NASDAQ:ONCY) Commences TNBC Study To Investigate The Use...
Oncolytics Biotech, Inc. (NASDAQ:ONCY) begins TNBC (triple-negative breast cancer) study, which is sponsored by the investigator. New Jersey-based Rutgers Cancer Institute (RCI) will manage...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Intellia Therapeutics Inc. (NASDAQ:NTLA) Posts Collaboration Revenue Of $22.2 Million In...
Intellia Therapeutics Inc. (NASDAQ:NTLA) has announced results of the quarter ended September 30, 2020, in which its collaboration revenue was $22.2 million. The revenue...
MAKE IT MODERN
LATEST REVIEWS
Is It Time to Take a Close Look at Cresco Labs...
Cresco Labs Inc. (OTC US:CRLBF) has been in a downward grind along with most of the big North American cannabis MSO’s over...
MAKE IT MODERN
PERFORMANCE TRAINING
Heat Biologics Inc. (NASDAQ:HTBX) Receives Investigational New Drug Application Approval From The FDA For...
Heat Biologics Inc. (NASDAQ:HTBX) has announced that it has received FDA clearance for the Investigational New Drug application for PTX-35, which is developed by...
9 Meters Biopharma Inc. (NASDAQ:NMTR) Receives Orphan Drug Designation for NM-003 in GvHD Prevention
9 Meters Biopharma Inc. (NASDAQ:NMTR) has received Orphan Drug designation from the US Food and Drug Administration. The grant is for its...
Compugen Ltd (NASDAQ:CGEN) Receives FDA IND Clearance For Phase 1/2 COM701 Study With Opdivo...
Compugen Ltd (NASDAQ:CGEN) has announced that the FDA has approved its Investigational New Drug Application for the Phase 1/2 study. The study will evaluate...
Mustang Bio Inc. (NASDAQ:MBIO) Signs Technology Transfer and GMP Manufacturing Deal With Minaris Regenerative...
Mustang Bio Inc. (NASDAQ:MBIO) and Minaris Regenerative Medicine GmBH have entered an agreement for technology transfer and GMP clinical manufacturing of MB-107. MB-107 is...
uniQure N.V. (NASDAQ: QURE) Doses First Two Subjects In the EU Clinical Study of...
uniQure N.V. (NASDAQ: QURE) has announced the dosing of the first two subjects in the European phase Ib/II clinical; study of AMT-130 in Europe....
MAKE IT MODERN
